Computational drug screening for drug-resistant tuberculosis: advances, challenges, and future perspectives
This review critically evaluates current computational strategies for anti-TB drug screening, with particular emphasis on their performance under TB-specific biological and resistance constraints, and proposes a shift toward biologically grounded, regimen-aware, and systems-level frameworks.